Summary:
HMD Research is conducting a research study for efficacy in controlling glycaemia with Victoza as add-on to metformin vs Oral Anti Diabetics as add on to metformin after up to 104 weeks of treatment in subjects with type 2 diabetes.
Qualified Participants Must:
• Be 18 years of age or older
•
Be clinically diagnosed with type 2 diabetes
•
Be currently on metformin
Qualified Participants May Receive:
Anti Diabetic Medication treatment for up to 104 weeks